These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29105783)

  • 21. Therapeutic considerations: symptoms, cells and mediators.
    Lightman S
    Allergy; 1995; 50(21 Suppl):10-3; discussion 34-8. PubMed ID: 7540364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The level of tryptase in human tears. An indicator of activation of conjunctival mast cells.
    Butrus SI; Ochsner KI; Abelson MB; Schwartz LB
    Ophthalmology; 1990 Dec; 97(12):1678-83. PubMed ID: 2087298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis.
    Fukuda K; Kuo CH; Morohoshi K; Liu FT; Ono SJ
    Br J Ophthalmol; 2012 Aug; 96(8):1132-6. PubMed ID: 22694967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tear and conjunctival changes during the allergen-induced early- and late-phase responses.
    Bacon AS; Ahluwalia P; Irani AM; Schwartz LB; Holgate ST; Church MK; McGill JI
    J Allergy Clin Immunol; 2000 Nov; 106(5):948-54. PubMed ID: 11080719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.
    Abelson MB; Schaefer K
    Surv Ophthalmol; 1993; 38 Suppl():115-32. PubMed ID: 7901917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities.
    Leonardi A; De Dominicis C; Motterle L
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):429-35. PubMed ID: 17873584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular allergic inflammation: interaction between the cornea and conjunctiva.
    Fukuda K; Nishida T
    Cornea; 2010 Nov; 29 Suppl 1():S62-7. PubMed ID: 20935545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular immunology of allergic conjunctivitis.
    Irkec MT; Bozkurt B
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):534-9. PubMed ID: 22885886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis.
    Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM
    Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular allergy guidelines: a practical treatment algorithm.
    Bielory L
    Drugs; 2002; 62(11):1611-34. PubMed ID: 12109924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
    Oh JW; Shin JC; Jang SJ; Lee HB
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of chemokines in ocular allergy and possible therapeutic strategies.
    Miyazaki D; Nakamura T; Komatsu N; Nawata N; Ikeda Y; Inoue Y; Higashi H; Ono SJ
    Cornea; 2004 Nov; 23(8 Suppl):S48-54. PubMed ID: 15448480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases.
    Shoji J
    Allergol Int; 2020 Oct; 69(4):496-504. PubMed ID: 32563624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells.
    Cook EB; Stahl JL; Sedgwick JB; Barney NP; Graziano FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):65-72. PubMed ID: 14756467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathophysiology of ocular allergy: current thinking.
    Foster CS
    Allergy; 1995; 50(21 Suppl):6-9; discussion 34-8. PubMed ID: 7785749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures.
    Leonardi A; Curnow SJ; Zhan H; Calder VL
    Clin Exp Allergy; 2006 Jun; 36(6):777-84. PubMed ID: 16776679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis.
    Kumagai N; Fukuda K; Fujitsu Y; Yamamoto K; Nishida T
    Prog Retin Eye Res; 2006 Mar; 25(2):165-87. PubMed ID: 16427347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.